The S&P 500 is at its most expensive by this measure. These stocks have bucked the trend.

The S&P 500 has reached an all-time high price/trailing sales ratio of 3.19, indicating the broad U.S. market is historically expensive, with the Information Technology sector notably overvalued at 9.76 times sales. This elevated valuation is largely driven by market-cap weighted large-cap tech, including the 'Magnificent Seven' stocks. Despite this trend, the article identifies 20 Nasdaq-100 companies that are trading below their 10-year average price/sales valuations while projecting high sales growth through 2027, offering potential opportunities amidst the broader market's premium.

Analysis

The U.S. stock market, particularly the S&P 500, is exhibiting signs of significant overvaluation based on the price-to-trailing-sales (P/S) metric, which has reached a historic high of 3.19, substantially above its 10-year average of 2.39. This valuation is heavily skewed by the market-capitalization weighting of the index, with the Information Technology sector trading at a P/S ratio of 9.76—an 87% premium to its decade average. The concentration is further highlighted by the 'Magnificent Seven' stocks, most of which trade at P/S multiples well above their own historical norms, with Tesla being a notable exception. In contrast to this broad market froth, a specific subset of 20 companies within the also-expensive Nasdaq-100 Index presents a compelling counter-narrative. These firms are currently trading below their 10-year average P/S valuations while simultaneously projecting high compound annual sales growth rates (CAGR) through 2027, significantly outpacing the 5.4% and 9.8% CAGR estimates for the S&P 500 and Nasdaq-100, respectively. This dichotomy suggests that while the market's headline valuation is stretched, opportunities for growth at a more reasonable valuation (GARV) exist for investors willing to look beyond broad market indices.

Key Decisions for Investors

• Given the S&P 500's record price-to-sales ratio, investors should review portfolios for concentration risk in overextended mega-cap technology and consider trimming positions where valuations appear most stretched relative to historical averages.
• Focus on identifying relative value by screening for companies, such as the 20 Nasdaq-100 stocks highlighted, that trade at a discount to their historical P/S multiples but possess superior forward-looking sales growth projections.
• For investors seeking to mitigate risks associated with a potential valuation-driven market correction, initiating or adding to positions in growth companies with more attractive relative valuations, like MercadoLibre or Datadog, could offer a strategic hedge.